Global Peripheral Vascular Disease Market - Focus on Technology (Stent, Drug-Coated Balloon, Atherectomy devices, Drug Eluting Stent (DES), PTA Balloon Catheter) Market Outlook 2022
April 5, 2018
Rockville Research
86
PDF
Global Peripheral Vascular Disease Market - Focus on Technology (Stent, Drug-Coated Balloon, Atherectomy devices, Drug Eluting Stent (DES), PTA Balloon Catheter) Market Outlook 2022
Abstract Peripheral vascular disease (PVD) is a circulatory system disorder outside of the brain and heart. It causes blood vessels (arteries and veins) to narrow down, causing blockage or spasm. The condition is referred to as coronary artery disease when narrowing of vessels occurs in the heart; and cerebrovascular disease in the case of brain. It mainly causes pain and fatigue especially in legs. PVD are mainly of two main types - functional and organic PVD. Functional PVD is associated with widening and narrowing of blood vessels in response to external stimuli, without physically damaging blood vessel’s structure. Organic PVD is caused by change in structure of blood vessels.
Treatment of peripheral vascular disease involves use of peripheral vascular devices for undergoing numerous procedures such as vascular stenting, atherectomy, chronic total occlusion repair, transcatheter embolization and vena cava filter implantation. Variety of medical devices are used for each procedure in multiple locations in the hospital. Global PVD market is driven by growth in incidence of peripheral vascular disease, increasing geriatric population, high restenosis rate and rising public awareness of PVD treatment. Around one-fourth of the world's population is possibly inflicted by peripheral artery disease itself. However, certain factors such as stringent regulatory compliance and high costs of treatment have emerged as major hurdles of the industry.
The report “Global Peripheral Vascular Disease Market – Focus on Technology (Stent, Drug-Coated Balloon, Atherectomy devices, Drug Eluting Stent (DES), PTA Balloon Catheter) Market Outlook 2022” provides information on the current scenario, detailed market outlook of the global peripheral vascular disease market with detailed analysis of major technologies such as Stent, Drug-Coated Balloon (DCB), Atherectomy devices, Drug Eluting Stent (DES), PTA Balloon Catheter. Future forecasts of global PVD market overall and across various sub-segments till 2022 is provided in the report. Country analysis of leading peripheral vascular disease devices market such as the US, China and Japan has been covered in the report. Furthermore, major industry players have been prudently analysed in the competitive landscape section of the report in order to provide key comparative insights.
Major industry players operating in the global PVD market include Boston Scientific, Medtronic plc, Abbott Laboratories, C.R. Bard, among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global peripheral vascular diseases market.
Content 1. Executive Summary 2. Research Methodology 3. Peripheral Vascular Disease 3.1 Overview 3.2 Types of PVD 3.2.1 Functional PVD 3.2.2 Organic PVD 3.4 Diagnosis of PVD 3.5 Treatment of PVD 4. Market Analysis 4.1 Market Sizing (Actual & Forecasted) 4.2 Market Share Analysis 4.2.1 Market Share by Devices 4.2.2 Market Share by Drugs 4.2.3 Market Share by Type of Disease 4.2.4 Market Share by Region 5. Country Analysis 5.1 The US 5.1.1 Market Sizing (Actual & Forecasted) 5.1.2 Market Share by Procedure 5.1.3 Market Share by Device 5.2 China 5.2.1 Market Sizing (Actual & Forecasted) 5.3 Japan 5.3.1 Market Sizing (Actual & Forecasted) 6. Market Segmentation 6.1 Peripheral Vascular Stent 6.1.1 Overview 6.1.2 Market Sizing (Actual & Forecasted) 6.1.3 Market Share by Segment 6.1.4 Market Share by Region 6.2 Drug-Coated Balloon (DCB) 6.2.1 Overview 6.2.2 Market Sizing (Actual & Forecasted) 6.3 Atherectomy Devices 6.3.1 Overview 6.3.2 Market Sizing (Actual & Forecasted) 6.4 Drug Eluting Stent (DES) 6.4.1 Overview 6.4.2 Market Sizing (Actual & Forecasted) 6.5 PTA Balloon Catheter 6.5.1 Overview 6.5.2 Market Sizing (Actual & Forecasted) 7. Pricing Analysis 8. Market Dynamics 8.1 Industry Trends & Development 8.1.1 Precision Vascular Robotics 8.1.2 Advent of Bioresorbable stent 8.1.3 Novel ‘3-D’ Stent System 8.1.4 Specialty Stents for PAD 8.1.5 Other New Technologies 8.2 Growth Drivers 8.2.1 Growing Geriatric Population 8.2.2 High Restenosis Rates 8.2.3 Rising Incidences of PAD 8.2.4 Increasing Public Awareness 8.3 Challenges 8.3.1 Strict Regulatory Compliance 8.3.2 High Cost of Treatment 8.3.3 Others 9. Competitive Landscape 9.1 Product Portfolio 9.1.1 Market Share by Competitors 10. Company Profiles 10.1 Boston Scientific 10.2 Medtronic plc 10.3 Abbott Laboratories 10.4 C.R. Bard
Peripheral vascular disease (PVD) is a circulatory system disorder outside of the brain and heart. It causes blood vessels (arteries and veins) to narrow down, causing blockage or spasm. The condition is referred to as coronary artery disease when narrowing of vessels occurs in the heart; and cerebrovascular disease in the case of brain. It mainly causes pain and fatigue especially in legs. PVD are mainly of two main types - functional and organic PVD. Functional PVD is associated with widening and narrowing of blood vessels in response to external stimuli, without physically damaging blood vessel’s structure. Organic PVD is caused by change in structure of blood vessels.
Treatment of peripheral vascular disease involves use of peripheral vascular devices for undergoing numerous procedures such as vascular stenting, atherectomy, chronic total occlusion repair, transcatheter embolization and vena cava filter implantation. Variety of medical devices are used for each procedure in multiple locations in the hospital. Global PVD market is driven by growth in incidence of peripheral vascular disease, increasing geriatric population, high restenosis rate and rising public awareness of PVD treatment. Around one-fourth of the world's population is possibly inflicted by peripheral artery disease itself. However, certain factors such as stringent regulatory compliance and high costs of treatment have emerged as major hurdles of the industry.
The report “Global Peripheral Vascular Disease Market – Focus on Technology (Stent, Drug-Coated Balloon, Atherectomy devices, Drug Eluting Stent (DES), PTA Balloon Catheter) Market Outlook 2022” provides information on the current scenario, detailed market outlook of the global peripheral vascular disease market with detailed analysis of major technologies such as Stent, Drug-Coated Balloon (DCB), Atherectomy devices, Drug Eluting Stent (DES), PTA Balloon Catheter. Future forecasts of global PVD market overall and across various sub-segments till 2022 is provided in the report. Country analysis of leading peripheral vascular disease devices market such as the US, China and Japan has been covered in the report. Furthermore, major industry players have been prudently analysed in the competitive landscape section of the report in order to provide key comparative insights.
Major industry players operating in the global PVD market include Boston Scientific, Medtronic plc, Abbott Laboratories, C.R. Bard, among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global peripheral vascular diseases market.
1. Executive Summary 2. Research Methodology 3. Peripheral Vascular Disease 3.1 Overview 3.2 Types of PVD 3.2.1 Functional PVD 3.2.2 Organic PVD 3.4 Diagnosis of PVD 3.5 Treatment of PVD 4. Market Analysis 4.1 Market Sizing (Actual & Forecasted) 4.2 Market Share Analysis 4.2.1 Market Share by Devices 4.2.2 Market Share by Drugs 4.2.3 Market Share by Type of Disease 4.2.4 Market Share by Region 5. Country Analysis 5.1 The US 5.1.1 Market Sizing (Actual & Forecasted) 5.1.2 Market Share by Procedure 5.1.3 Market Share by Device 5.2 China 5.2.1 Market Sizing (Actual & Forecasted) 5.3 Japan 5.3.1 Market Sizing (Actual & Forecasted) 6. Market Segmentation 6.1 Peripheral Vascular Stent 6.1.1 Overview 6.1.2 Market Sizing (Actual & Forecasted) 6.1.3 Market Share by Segment 6.1.4 Market Share by Region 6.2 Drug-Coated Balloon (DCB) 6.2.1 Overview 6.2.2 Market Sizing (Actual & Forecasted) 6.3 Atherectomy Devices 6.3.1 Overview 6.3.2 Market Sizing (Actual & Forecasted) 6.4 Drug Eluting Stent (DES) 6.4.1 Overview 6.4.2 Market Sizing (Actual & Forecasted) 6.5 PTA Balloon Catheter 6.5.1 Overview 6.5.2 Market Sizing (Actual & Forecasted) 7. Pricing Analysis 8. Market Dynamics 8.1 Industry Trends & Development 8.1.1 Precision Vascular Robotics 8.1.2 Advent of Bioresorbable stent 8.1.3 Novel ‘3-D’ Stent System 8.1.4 Specialty Stents for PAD 8.1.5 Other New Technologies 8.2 Growth Drivers 8.2.1 Growing Geriatric Population 8.2.2 High Restenosis Rates 8.2.3 Rising Incidences of PAD 8.2.4 Increasing Public Awareness 8.3 Challenges 8.3.1 Strict Regulatory Compliance 8.3.2 High Cost of Treatment 8.3.3 Others 9. Competitive Landscape 9.1 Product Portfolio 9.1.1 Market Share by Competitors 10. Company Profiles 10.1 Boston Scientific 10.2 Medtronic plc 10.3 Abbott Laboratories 10.4 C.R. Bard